American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Arcturus Therapeutics Holdings Inc. (ARCT)

$11.23 +13.32% NASDAQ: ARCT · 15-min delayed

SAN DIEGO, California
Public · NASDAQ: ARCT
111 employees

Visit website Follow

$157.2MMarket cap

$82.0MRevenue · FY2025

-$65.8MNet income

111Employees

ARCTNASDAQ

2013IPO

About Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: ARCT
Employees: 111
IPO date: May 22, 2013
Headquarters: 10285 SCIENCE CENTER DRIVE
SAN DIEGO, California
Phone: (858) 900-2660
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: ARCT Nasdaq
SEC CIK: 1768224
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Arcturus Therapeutics Holdings Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/arcturus-therapeutics-holdings-inc/"><img src="https://americancompanies.com/badge/arcturus-therapeutics-holdings-inc.svg" alt="Arcturus Therapeutics Holdings Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Arcturus Therapeutics Holdings Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $82.0M
Net income: -$65.8M
Total assets: $271.1M
Market cap: $157.2M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: ARCT

$11.23 +13.32%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$5.53 $23.16

52-week range

Market cap: $157.2M
Shares outstanding: 14.0M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: May 22, 2013

Arcturus Therapeutics Holdings Inc. (ARCT) Stock Price

Reported a net loss of $65.8M in FY2025.
Trading 52% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Arcturus Therapeutics Holdings Inc..

Write a review

Newsroom

News about Arcturus Therapeutics Holdings Inc.

mRNA Therapeutics Market Outlook Report 2026-2035 Featuring Profiles of Arcturus Therapeutics, BioNTech, CureVac, Moderna, Providence Therapeutics, RNAimmune, Recode Therapeutics, and More GlobeNewswire Inc. · 2026-08-26 · neutral These Are the Only 3 Stocks That Cathie Wood Bought Last Week The Motley Fool · 2026-03-23 · positive Cathie Wood Goes Shopping: 3 Stocks She Just Bought The Motley Fool · 2025-10-23 · negative 10 Health Care Stocks With Whale Alerts In Today's Session Benzinga · 2025-09-29 · negative Lipid Nanoparticles Market Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2034 GlobeNewswire Inc. · 2025-08-05 · neutral RNA Therapeutics and RNA Vaccines Market Industry Report 2025-2035: Investments in RNA Technologies Surge with USD 2.9 Billion Funding GlobeNewswire Inc. · 2025-07-18 · positive

News & sentiment via Polygon.io

FAQ

Arcturus Therapeutics Holdings Inc.: frequently asked questions

Is Arcturus Therapeutics Holdings Inc. an American company?

Arcturus Therapeutics Holdings Inc. is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Arcturus Therapeutics Holdings Inc. headquartered?

Arcturus Therapeutics Holdings Inc. is headquartered in San Diego, California, United States.

Is Arcturus Therapeutics Holdings Inc. publicly traded?

Yes — Arcturus Therapeutics Holdings Inc. is a publicly traded company. Its stock trades under the ticker symbol ARCT on the NASDAQ.

What does Arcturus Therapeutics Holdings Inc. do?

Arcturus Therapeutics Holdings Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore